Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Landmark approval for Dendreon's cancer vaccine.

× No keyword cloud information.

2 in total

1. The regulator disapproves.

Authors:
Journal: Nat Biotechnol Date: 2008-01 Impact factor: 54.908

2. The cancer vaccine roller coaster.

Authors: Bruce Goldman; Laura DeFrancesco
Journal: Nat Biotechnol Date: 2009-02 Impact factor: 54.908

2 in total

17 in total

1. The immunotherapy revolution in genitourinary malignancies.

Authors: Shruti U Gandhy; Ravi A Madan; Jeanny B Aragon-Ching
Journal: Immunotherapy Date: 2020-06-29 Impact factor: 4.196

Review 2. Dendritic cell vaccines in cancer immunotherapy: from biology to translational medicine.

Authors: Hongmei Xu; Xuetao Cao
Journal: Front Med Date: 2011-12 Impact factor: 4.592

Review 3. Therapeutic cancer vaccines: are we there yet?

Authors: Christopher A Klebanoff; Nicolas Acquavella; Zhiya Yu; Nicholas P Restifo
Journal: Immunol Rev Date: 2011-01 Impact factor: 12.988

4. Giving oncolytic vaccinia virus more BiTE.

Authors: Steven M Albelda; Steve H Thorne
Journal: Mol Ther Date: 2014-01 Impact factor: 11.454

5. Trade secrets in balance as agencies issue new transparency rules.

Authors: Gunjan Sinha
Journal: Nat Biotechnol Date: 2011-02 Impact factor: 54.908

Review 6. Cancer immunotherapy--revisited.

Authors: W Joost Lesterhuis; John B A G Haanen; Cornelis J A Punt
Journal: Nat Rev Drug Discov Date: 2011-08-01 Impact factor: 84.694

7. Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2C.

Authors: Adam E Snook; Michael S Magee; Glen P Marszalowicz; Stephanie Schulz; Scott A Waldman
Journal: Cancer Immunol Immunother Date: 2011-11-06 Impact factor: 6.968

8. Selective antigen-specific CD4(+) T-cell, but not CD8(+) T- or B-cell, tolerance corrupts cancer immunotherapy.

Authors: Adam E Snook; Michael S Magee; Stephanie Schulz; Scott A Waldman
Journal: Eur J Immunol Date: 2014-05-21 Impact factor: 5.532

9. Human dendritic cells derived from embryonic stem cells stably modified with CD1d efficiently stimulate antitumor invariant natural killer T cell response.

Authors: Jieming Zeng; Shu Wang
Journal: Stem Cells Transl Med Date: 2013-11-29 Impact factor: 6.940

10. Regulating cytokine function enhances safety and activity of genetic cancer therapies.

Authors: Hannah Chen; Padma Sampath; Weizhou Hou; Stephen H Thorne
Journal: Mol Ther Date: 2012-11-13 Impact factor: 11.454